← Back to headlines
The Decline of BioNTech, the Pandemic's Vaccine Hero
A report on how BioNTech, the German pharmaceutical company that developed the first approved mRNA COVID-19 vaccine, has seen its fortunes decline six years after its pandemic peak.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
